Rewalk Roboti Ord conducts business under
Healthcare sector and is part of
Medical Devices industry. The entity currently holds 1.3
M in liabilities with Debt to Equity (D/E) ratio of 0.02, which may suggest the company is not taking enough advantage from borrowing. The firm has a current ratio of 16.14, suggesting that it is liquid enough and is able to pay its financial obligations when due.
Investing in Rewalk Robotics, just like investing in any other equity instrument, is characterized by a strong risk-return correlation. High risks mean high returns and low risk means lower expected returns. Risk management is the act of identifying and assessing the potential risk and developing strategies to minimize these risks and earn maximum possible profits while holding Rewalk Robotics along with other instruments in the same portfolio. Using conventional
technical analysis and
fundamental analysis to select individual securities into a portfolio complements risk management and adds value to overall investors' investing strategies.
Sophisticated investors, who have witnessed
many market ups and downs, anticipate that the market will even out over time. This tendency of Rewalk Robotics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Rewalk Robotics. Your research has to be compared to or analyzed against Rewalk Robotics' peers to derive any actionable benefits. When done correctly, Rewalk Robotics' competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in Rewalk Robotics.
Watch out for price decline
Please consider monitoring Rewalk Robotics on a daily basis if you are holding a position in it. Rewalk Robotics is trading at a penny-stock level, and the possibility of delisting is much higher compared to other delisted stocks. However, just because the stock is trading under one dollar, does not mean it will be marked for deletion.
Most exchanges require public instruments, such as Rewalk Robotics stock to be traded above the $1 level to remain listed. If Rewalk Robotics stock price falls below $1 for 30 consecutive trading days, the exchange can delist it. Once the company reaches this point, they will be sent an initial price violation notice directly from an exchange.
How important is Rewalk Robotics's Liquidity
Rewalk Robotics
financial leverage refers to using borrowed capital as a funding source to finance Rewalk Robotics ongoing operations. It is usually used to expand the firm's asset base and generate returns on borrowed capital. Rewalk Robotics financial leverage is typically calculated by taking the company's all interest-bearing debt and dividing it by total capital. So the higher the debt-to-capital ratio (i.e., financial leverage), the riskier the company. Financial leverage can amplify the potential profits to Rewalk Robotics' owners, but it also increases the potential losses and risk of financial distress, including bankruptcy, if the firm cannot cover its debt costs. The degree of Rewalk Robotics' financial leverage can be measured in several ways, including by ratios such as the debt-to-equity ratio (total debt / total equity), equity multiplier (total assets / total equity), or the debt ratio (total debt / total assets). Please check the
breakdown between Rewalk Robotics's total debt and its cash.
Rewalk Robotics Correlation with Peers
Investors in Rewalk can reduce exposure to individual asset risk by holding a diversified portfolio of assets in addition to a long position in Rewalk Robotics. Diversification will allow for the same portfolio return with reduced risk. The correlation table of Rewalk Robotics and its peers is a two-dimensional matrix that shows the correlation coefficient between pairs of securities Rewalk is related in some way. The cells in the table are color-coded to highlight significantly positive and negative relationships. Each cell shows the correlation between one pair of equities and can be used to run pair trading strategies or create efficient portfolios with
your current brokerage. Please check
volatility of Rewalk for more details
An Additional Perspective On Rewalk Robotics
Rewalk Roboti appears to be extremely dangerous, given 3 months investment horizon.
Rewalk Roboti Ord maintains Sharpe Ratio (i.e., Efficiency) of 0.0458, which implies the firm had 0.0458% of return per unit of risk over the last 3 months. Our standpoint towards forecasting the volatility of a stock is to use all available market data together with stock-specific
technical indicators that cannot be
diversified away. By analyzing
Rewalk Roboti Ord technical indicators you can presently evaluate if the expected return of 0.62% is justified by implied risk. Please evaluate Rewalk Roboti's Semi Deviation of 5.37,
coefficient of variation of 1893.35, and Risk Adjusted Performance of 0.0449 to confirm if our risk estimates are consistent with your expectations.
Rewalk Roboti recent plunge is nasty
Recent mean deviation is at 4.61. Rewalk Roboti Ord is displaying above-average volatility over the selected time horizon. Investors should scrutinize Rewalk Roboti Ord independently to ensure intended market timing strategies are aligned with expectations about Rewalk Roboti volatility. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Rewalk Roboti's stock risk against market volatility during both bullying and bearish trends. The higher level of volatility that comes with bear markets can directly impact Rewalk Roboti's stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different stocks as prices fall.
The Bottom Line
Although some firms in the medical devices industry are either recovering or due for a correction, Rewalk may not be as strong as the others in terms of longer-term growth potentials. The inconsistency in the assessment between current Rewalk valuation and our trade advice on Rewalk Roboti is due to the recent market swings and your selection of investing horizon. Please use our equity advice module to run different scenarios to ensure your current risk level and investment horizon are fully reflective of your current investing preferences in regards to Rewalk Roboti.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectEditorial Staff
Raphi Shpitalnik is a Junior Member of Macroaxis Editorial Board. Raphael is a young entrepreneur who joined Macroaxis on a part-time basis at the beginning of the pandemic and eventually acquired a real taste for investing and fintech. He likes to analyze different equity instruments across a wide range of industries, focusing primarily on consumer products, sports, fintech, cannabis, and AI.
View Profile This story should be regarded as informational only and should not be considered a solicitation to sell or buy any financial products. Macroaxis does not express any opinion as to the present or future value of any investments referred to in this post. This post may not be reproduced without the consent of Macroaxis LLC. Macroaxis LLC and Raphi Shpitalnik do not own shares of Rewalk Robotics. Please refer to our
Terms of Use for any information regarding our disclosure principles.
Would you like to provide feedback on the content of this article?
You can get in touch with us directly or send us a quick note via email to
editors@macroaxis.com
